<DOC>
	<DOCNO>NCT02230228</DOCNO>
	<brief_summary>This protocol phase 1 clinical study ass safety pharmacokinetics ALK-001 healthy volunteer . Please contact trial @ alkeus.com question .</brief_summary>
	<brief_title>Phase 1 Safety Study ALK-001 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Retinal Dystrophies</mesh_term>
	<criteria>Main Inclusion Criteria Adult 21 70 year old ( inclusive ) Healthy subject , judge investigator Subject able willing comply study requirement ( study medication compliance , schedule followup visit ) Subject provide informed consent participate If female , subject use medically accepted birth control method agree use method entire clinical trial period Main Subject take disallow item past 30 day Female positive urine pregnancy test screen Lactating woman Subject participate clinical study involve investigational drug , biologic device , past 30 day History current evidence gastrointestinal malabsorption Subject medical condition , opinion investigator , likely prevent compliance protocol and/or interfere successful collection study Subject , opinion investigator , clinically significant laboratory result ( ) , positive drug alcohol screening , ECG , make subject unsuitable participation .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>